Cervomed Stock Shares Owned By Insiders
| CRVO Stock | 9.33 0.50 5.66% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess CervoMed's long-term financial health and intrinsic value.
CervoMed | Shares Owned By Insiders | Build AI portfolio with CervoMed Stock |
CervoMed Company Shares Owned By Insiders Analysis
CervoMed's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current CervoMed Shares Owned By Insiders | 33.38 % |
Most of CervoMed's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CervoMed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CervoMed Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for CervoMed is extremely important. It helps to project a fair market value of CervoMed Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since CervoMed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CervoMed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CervoMed's interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 33.38% of CervoMed are shares owned by insiders. This is 119.89% higher than that of the Biotechnology sector and 135.4% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
CervoMed Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CervoMed's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CervoMed could also be used in its relative valuation, which is a method of valuing CervoMed by comparing valuation metrics of similar companies.CervoMed is currently under evaluation in shares owned by insiders category among its peers.
CervoMed ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CervoMed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CervoMed's managers, analysts, and investors.Environmental | Governance | Social |
CervoMed Fundamentals
| Return On Equity | -0.93 | ||||
| Return On Asset | -0.56 | ||||
| Profit Margin | (2.01) % | ||||
| Operating Margin | (2.77) % | ||||
| Current Valuation | 42.12 M | ||||
| Shares Outstanding | 8.7 M | ||||
| Shares Owned By Insiders | 33.38 % | ||||
| Shares Owned By Institutions | 26.28 % | ||||
| Number Of Shares Shorted | 109.92 K | ||||
| Price To Book | 2.23 X | ||||
| Price To Sales | 8.26 X | ||||
| Revenue | 9.74 M | ||||
| Gross Profit | (11.51 M) | ||||
| EBITDA | (18.23 M) | ||||
| Net Income | (16.29 M) | ||||
| Total Debt | 3.88 M | ||||
| Book Value Per Share | 3.98 X | ||||
| Cash Flow From Operations | (16.53 M) | ||||
| Short Ratio | 0.68 X | ||||
| Earnings Per Share | (2.17) X | ||||
| Target Price | 17.67 | ||||
| Number Of Employees | 15 | ||||
| Market Capitalization | 76.85 M | ||||
| Total Asset | 43.08 M | ||||
| Retained Earnings | (70.73 M) | ||||
| Working Capital | 39.2 M | ||||
| Net Asset | 43.08 M |
About CervoMed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CervoMed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CervoMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CervoMed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with CervoMed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CervoMed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CervoMed will appreciate offsetting losses from the drop in the long position's value.Moving against CervoMed Stock
| 0.68 | DRTS | Alpha Tau Medical | PairCorr |
| 0.67 | A | Agilent Technologies Earnings Call Today | PairCorr |
| 0.67 | VIGL | Vigil Neuroscience | PairCorr |
| 0.42 | VERV | Verve Therapeutics Earnings Call This Week | PairCorr |
| 0.36 | SABSW | SAB Biotherapeutics | PairCorr |
The ability to find closely correlated positions to CervoMed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CervoMed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CervoMed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CervoMed to buy it.
The correlation of CervoMed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CervoMed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CervoMed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CervoMed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out CervoMed Piotroski F Score and CervoMed Altman Z Score analysis. To learn how to invest in CervoMed Stock, please use our How to Invest in CervoMed guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CervoMed. If investors know CervoMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CervoMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.17) | Revenue Per Share | Quarterly Revenue Growth (0.18) | Return On Assets | Return On Equity |
The market value of CervoMed is measured differently than its book value, which is the value of CervoMed that is recorded on the company's balance sheet. Investors also form their own opinion of CervoMed's value that differs from its market value or its book value, called intrinsic value, which is CervoMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CervoMed's market value can be influenced by many factors that don't directly affect CervoMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CervoMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if CervoMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CervoMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.